Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds-Reference-Cited by-同舟云学术

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Published:2015-03 Issue:8 Volume:65 Page:791-801
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Puricel Serban,Arroyo Diego,Corpataux Noé,Baeriswyl Gérard,Lehmann Sonja,Kallinikou Zacharenia,Muller Olivier,Allard Ludovic,Stauffer Jean-Christophe,Togni Mario,Goy Jean-Jacques,Cook Stéphane

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials;Dibra;J Am Coll Cardiol,2007

2. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk;Joner;J Am Coll Cardiol,2006

3. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial;Kedhi;Lancet,2010

4. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial;Park;J Am Coll Cardiol,2011

5. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N Engl J Med,2010

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial;Frontiers in Cardiovascular Medicine;2024-09-10

2. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

3. Advancements in Percutaneous Coronary Intervention Techniques: A Comprehensive Literature Review of Mixed Studies and Practice Guidelines;Cureus;2023-07-03

4. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials;Open Heart;2022-10

5. Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2022-09-08